ArisGlobal Newscast: Industry’s Only E2B R3 Compliant Safety Multi-Tenant Cloud Platform
LifeSphere® Safety MultiVigilance is the only E2B R3 compliant multi-tenant ...
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
LifeSphere® Safety MultiVigilance is the only E2B R3 compliant multi-tenant ...
As different regulatory authorities have different timelines for adoption of these standards, E2B(R2) E2B(R3) will have to coexist. But having to operate two solutions creates huge complexities, unless you find a solution compliant with both. ArisGlobal LifeSphere Safety MultiVigilance is the only drug safety database solution provider thus far to provide full compliance to E2B R2 and E2B R3 standards for both import and export.
Artificial intelligence (AI), machine learning, deep learning, natural language processing ...
The clinical trial sector witnessed a lot of action in ...
Silos have long plagued the life sciences industry, and nowhere ...
CUSTOMER BACKGROUND With a history dating back to the late ...
CUSTOMER BACKGROUND Customer is a leading global pharmaceutical company headquartered ...
Customer Background Incorporated in 1993 as a subsidiary of Biocon ...
The client, a mid-tier biotechnology company with products in a range of therapeutic areas, was struggling with an all-too-familiar challenge: How to effectively collect, organize, triage and archive the large volume of inbound potential AE (Adverse Event) and ADR (Adverse Drug Reaction) reports they received for case processing and reporting.
Global CRO PPD selects ArisGlobal’s cloud-based drug safety database solution to provide its clients with continuous pharmacovigilance regulatory reporting compliance in the most cost-effective way.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved